Zelluna ASA: Invitation to First Quarter 2026 results webcast Presentation

Oslo, Norway, 4 May 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, invites to a webcast presentation of its first quarter 2026 results on Thursday, 7 May 2026.

The presentation will be available via a live webcast on www.zelluna.com at 09:00 CEST on Thursday, 7 May 2026. The webcast recording will remain available on the company’s website after the event, and participants will be able to submit questions during the presentation.

The quarterly report and presentation materials will be published on the company’s website at 07:00 CEST on the same day.

For further information, please visit www.zelluna.com or contact:

Namir Hassan, CEO
Email: [email protected]
Phone: +44 7720 687608

Geir Christian Melen, CFO
Email: [email protected]
Phone: +47 913 02 965

You May Also Be Interested In

• Pardu Productions Publishes Exclusive Feature on Marc Mysterio's Proposed “Name vs. Name” Match
• David Ferrera Announces New Neurovascular and Medical Device Manufacturing Ventures in the Middle East and Africa
• International Association for the Study of Lung Cancer Launches Complimentary IASLC Full Membership for Eligible Countries to Expand Worldwide Participation in Thoracic Oncology